Shandong Keyuan Pharmaceutical CoSZSE:301281 -1.12%67 Operating Margin % is 22.46% as of Mar. 2026, which is 22% above its 10-year median of 18.39. GuruFocus rates SZSE:301281 with a GF Score™ of 67/100 and a GF Value™ of ¥30.41 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 961 Drug Manufacturers companies, Shandong Keyuan Pharmaceutical Co ranks better than 67.01% on this metric.
Shandong Keyuan Pharmaceutical Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -14%.
The historical rank and industry rank for Shandong Keyuan Pharmaceutical Co's Operating Margin % or its related term are showing as below:
SZSE:301281'
s Operating Margin % Range Over the Past 10 Years
Min: 11.2 Med: 18.39 Max: 22.28
Current: 13.93
SZSE:301281's Operating Margin % is ranked better than 67.01% of 961
companies
in the Drug Manufacturers industry
Industry Median: 7.57
vs SZSE:301281: 13.93
Shandong Keyuan Pharmaceutical Co Ltd has recorded a loss in operating income at least once over the past 3 years.
Shandong Keyuan Pharmaceutical Co (SZSE:301281) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Shandong Keyuan Pharmaceutical Co Operating Margin % Related Terms
Shandong Keyuan Pharmaceutical Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co Operating Margin % Chart
SZSE:301281 vs LLY, JNJ, ABBV: Operating Margin % Comparison
For the Drug Manufacturers - General subindustry, Shandong Keyuan Pharmaceutical Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Keyuan Pharmaceutical Co Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shandong Keyuan Pharmaceutical Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Keyuan Pharmaceutical Co's Operating Margin % falls into.
Shandong Keyuan Pharmaceutical Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a Operating Margin % of 22.46% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. This is 22% above median its historical median of 18.39. Over the past decade, Shandong Keyuan Pharmaceutical Co's Operating Margin % has ranged from 11.20 to 22.28. According to the industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #317 out of 961 companies in the Drug Manufacturers industry, placing it in the top 33%.
Is Shandong Keyuan Pharmaceutical Co's Operating Margin % too high?
Shandong Keyuan Pharmaceutical Co's current Operating Margin % of 22.46% is 22% above median its 10-year median of 18.39. Over the past 10 years, this metric has ranged from a low of 11.20 to a high of 22.28. The Drug Manufacturers industry median Operating Margin % is 7.57. Shandong Keyuan Pharmaceutical Co's value of 22.46% is 196.7% above this industry median. Based on the distribution chart, Shandong Keyuan Pharmaceutical Co ranks #317 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's Operating Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #317 out of 961 companies for Operating Margin %. This puts Shandong Keyuan Pharmaceutical Co in the upper half of its industry. The industry median Operating Margin % is 7.57. Shandong Keyuan Pharmaceutical Co's value of 22.46% is 196.7% above this benchmark. Historically, Shandong Keyuan Pharmaceutical Co's own Operating Margin % has ranged from 11.20 to 22.28 over the past decade. While the company's 10-year median is 18.39 vs. the industry median of 7.57, Shandong Keyuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.57, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Keyuan Pharmaceutical Co's current Operating Margin % of 22.46% is 196.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Keyuan Pharmaceutical Co's current Operating Margin % is 22.46%, which is 22% above median its own 10-year median of 18.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.41, compared to a current price of ¥50.42 — trading 65.8% above its estimated fair value. The current Operating Margin % is 22.46%, which is 22% above median its 10-year median of 18.39 and 196.7% above the Drug Manufacturers industry median of 7.57. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current Operating Margin % is 22.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥50.42 is trading 65.8% above its estimated GF Value™ of ¥30.41.
GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SZSE:301281:
Operating Margin %: 22.46% (22% above median its 10-year median of 18.39)
GF Value™: ¥30.41 vs. price of ¥50.42 (65.8% above fair value)
Industry Position: 196.7% above the Drug Manufacturers median (#317 of 961)
No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Keyuan Pharmaceutical Co Business Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score
Get the complete analysis for SZSE:301281
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301281 has been successfully added to your 
